Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
de Bruijne, J.
1808  Ergebnisse:
Personensuche X
?
1

Carte du Ciel andGaia: I. Astrometry:

Lehtinen, K. ; Prusti, T. ; de Bruijne, J....
Astronomy & Astrophysics.  671 (2023)  - p. A16 , 2023
Link: https://doi.org/10.1051/..
 
?
2

Intra-gastric balloon with lifestyle modification: a promis..:

van Dijk, A. M. ; de Vries, M. ; El-Morabit, F....
Internal and Emergency Medicine.  18 (2023)  8 - p. 2271-2280 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepati..:

van Wezel, E M ; de Bruijne, J ; Damman, K...
Open Forum Infectious Diseases.  6 (2019)  8 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
4

Miravirsen dosing in chronic hepatitis C patients results i..:

van der Ree, M. H. ; van der Meer, A. J. ; van Nuenen, A. C....
Alimentary Pharmacology & Therapeutics.  43 (2015)  1 - p. 102-113 , 2015
Link: https://doi.org/10.1111/..
 
?
5

P1097 LONG-TERM SAFETY AND EFFICACY OF MIRAVIRSEN IN CHRONI..:

van der Ree, M.H. ; van der Meer, A.J. ; de Bruijne, J....
Journal of Hepatology.  60 (2014)  1 - p. S443 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Estimating Gaia's performance for O stars in the Outer Gala..:

Rygl, K.L.J. ; Molinari, S. ; Prusti, T....
EAS Publications Series.  67-68 (2014)  - p. 397-397 , 2014
Link: https://doi.org/10.1051/..
 
?
7

Sustained virologic response after therapy with the HCV pro..:

Hotho, D. M. ; de Bruijne, J. ; Spaan, M....
Journal of Viral Hepatitis.  20 (2013)  4 - p. , 2013
Link: https://doi.org/10.1111/..
 
?
8

Upregulation of CXCR3 expression on CD8+ T cells due to the..:

de Niet, A. ; de Bruijne, J. ; Plat-Sinnige, M.J. Tempelmans...
Human Immunology.  74 (2013)  8 - p. 899-906 , 2013
Link: https://doi.org/10.1016/..
 
?
9

Evolutionary dynamics of hepatitis C virus NS3 protease dom..:

de Bruijne, J. ; Thomas, X. V. ; Rebers, S. P....
Journal of Viral Hepatitis.  20 (2013)  11 - p. 779-789 , 2013
Link: https://doi.org/10.1111/..
 
?
10

1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOT..:

Lenz, O. ; de Bruijne, J. ; Vijgen, L....
Journal of Hepatology.  54 (2011)  - p. S482-S483 , 2011
Link: https://doi.org/10.1016/..
 
?
11

Randomised clinical trial: anti-viral activity of ANA773, a..:

Bergmann, J. F. ; de Bruijne, J. ; Hotho, D. M....
Alimentary Pharmacology & Therapeutics.  34 (2011)  4 - p. 443-453 , 2011
Link: https://doi.org/10.1111/..
 
?
12

1242 LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS C INFECTED PA..:

Thomas, X.V. ; de Bruijne, J. ; Kieffer, T.L....
Journal of Hepatology.  54 (2011)  - p. S490-S491 , 2011
Link: https://doi.org/10.1016/..
 
?
13

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CH..:

de Bruijne, J. ; Bergmann, J.F. ; Weegink, C.J....
Journal of Hepatology.  52 (2010)  - p. S290-S291 , 2010
Link: https://doi.org/10.1016/..
 
?
14

P.031 Emergence of hepatitis C virus genotype 4 in the Neth..:

van de Laar, T.J.W. ; de Bruijne, J. ; Schinkel, J....
Journal of Clinical Virology.  44 (2009)  - p. S24 , 2009
Link: https://doi.org/10.1016/..
 
?
15

86 SAFETY AND ANTIVIRAL ACTIVITY OF SCH 900518 ADMINISTERED..:

Reesink, H. ; Bergmann, J. ; de Bruijne, J....
Journal of Hepatology.  50 (2009)  - p. S35-S36 , 2009
Link: https://doi.org/10.1016/..
 
1-15